Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Izumi (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Uchimura (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan). Population based survey on the NTM pulmonary disease treatment in Japan. 346

Member's Comments

No comment yet.

Related content which might interest you: Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Evolution of pulmonary tuberculosis disease in a county of Spain Source: Eur Respir J 2001; 18: Suppl. 33, 472s Year: 2001 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Study of molecular-genetic mutations of tuberculosis mycobacteria in patients with pulmonary TB in Azerbaijan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Remarkable diversity in the geographic distribution of NTM species in Bursa, Turkey: Analysis of nontuberculous mycobacterial pulmonary disease in a two years retrospective cohort Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Actual treatment practices of pulmonary nontuberculous mycobacteriosis analysed from national insurance claim data in Japan Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018 Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Microbiological diagnosis of NTM pulmonary disease Source: International Congress 2017 – Clinical impact of nontuberculous mycobacterial (NTM) disease Year: 2017 Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases Source: International Congress 2016 – Orphan diseases I Year: 2016 Burden of non-tuberculous mycobacterial pulmonary disease in Germany Source: Eur Respir J , 49 (4)  1602109; DOI: 10.1183/13993003.02109-2016 Year: 2017 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020